Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Journal of Clinical & Experimental OncologyISSN: 2324-9110
Peifeng Tang Author
Subjects of specialization
Affiliation
Colorectal cancer, Cancer chemotherapy, Prostate biomarker, Endometrial cancer, Carbofuran
Department of Process Development, Mab-Venture Biopharm Co. Ltd., Shanghai, China.
Biography
Peifeng Tang was working in the Department of Process Development, Mab-Venture Biopharm Co. Ltd., Shanghai, China and aliso in the Department of Paper and Bioprocess Engineering, State University of New York-College of Environmental Science and Forestry, Syracuse, New York, USA.
Publications
Review Article Open Access
Screening of Monoclonal Antibodies for Cancer Treatment
Author(s): Peifeng Tang, Shaoyan Liang, Jianlin Xu, Shaoxiong Wang, Lijun Wang and Shijie Liu*
With the rapid development of cancer treatment using monoclonal antibodies (mAbs), the screening process of suitable biologics and indications attracts much attention. A general definition of ‘screening’ in the biopharmaceutical industry includes three aspects: the appropriate biologics for the specific cancers, the appropriate indications for the specific biologics and the promising biologic candidates from the pool at the pre-clinical drug discovery stage. Effective screening strategies in the biopharmaceutical industry are crucial to accelerate the drug commercialization process and select the effective biologics for patients. The current status of commercial mAbs and the global pharmaceutical market was briefly reviewed. The mechanism of comm... view more»
Google Scholars / Researchers Sites
